SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
SEC Accession No. 0001193125-17-035798
Filing Date
2017-02-09
Accepted
2017-02-09 13:45:32
Documents
2
Group Members
ARNOLD L. ORONSKYGILBERT H. KLIMANINTERWEST MANAGEMENT PARTNERS IX, LLCKHALED A. NASRPHILIP T. GIANOSW. STEPHEN HOLMES III

Document Format Files

Seq Description Document Type Size
1 SC 13D/A d348148dsc13da.htm SC 13D/A 145537
2 EX-99.A d348148dex99a.htm EX-99.A 6430
  Complete submission text file 0001193125-17-035798.txt   153809
Mailing Address 525 UNIVERSITY AVENUE SUITE 610 PALO ALTO CA 94301
Business Address 525 UNIVERSITY AVENUE SUITE 610 PALO ALTO CA 94301 6504625800
Ocera Therapeutics, Inc. (Subject) CIK: 0001274644 (see all company filings)

IRS No.: 631192270 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-86177 | Film No.: 17586796
SIC: 2834 Pharmaceutical Preparations

Mailing Address 2710 SAND HILL ROAD SUITE 200 MENLO PARK CA 94025
Business Address 2710 SAND HILL ROAD SUITE 200 MENLO PARK CA 94025 650-854-8585
InterWest Partners IX, LP (Filed by) CIK: 0001398928 (see all company filings)

IRS No.: 202312479 | State of Incorp.: CA | Fiscal Year End: 1231
Type: SC 13D/A